reconstitution protocol FAQ

Discard the vial immediately. Do not attempt to use it. Cloudiness indicates either bacterial contamination (if stored at room temperature or for longer than 28 days) or peptide aggregation (if exposed to temperature fluctuations above 8°C). Colour change. Particularly yellowing or browning. Signals oxidative degradation of amino acid residues. Neither condition is reversible, and injecting degraded peptide introduces unknown byproducts with unpredictable biological activity. This is why proper refrigerated storage at 2–8°C is critical from the moment reconstitution is complete until the vial is empty or 28 days have passed, whichever comes first.

Use the reconstituted SS-31 within 24 hours and do not re-access the vial after the first withdrawal. Sterile water lacks preservative, so bacterial contamination begins within 48–72 hours once the vial seal is punctured. If your research protocol requires multiple doses over several days, reconstitute a new vial with bacteriostatic water rather than continuing to use the sterile-water preparation. Freezing is not an option. Freeze-thaw cycles cause SS-31 to aggregate even if the initial solution was clear.

Use the entire vial within 24 hours or discard it. Sterile water lacks the benzyl alcohol preservative that prevents bacterial proliferation in multi-dose vials. Every needle puncture introduces potential contaminants that multiply rapidly without antimicrobial protection. If your protocol requires doses spread over weeks, reconstitute a new vial with bacteriostatic water rather than risk infection from a compromised solution.

Bacterial growth becomes the primary risk after 8–12 hours at room temperature, even with bacteriostatic water's preservative. The peptide itself remains structurally stable at 20–25°C for 24–48 hours, but contamination risk escalates. If the vial was left out for one night (8–10 hours), inspect it carefully for any discolouration or particulate matter, then refrigerate immediately and use within 7 days instead of the standard 28-day window. If it was left out for more than 24 hours, discard it.

Do not use it. Cloudiness or particulate matter indicates protein aggregation, contamination, or incomplete dissolution. All of which mean the peptide is no longer suitable for research applications. Aggregated SNAP-8 cannot be 'fixed' by additional mixing or filtration. Once the tertiary structure collapses into aggregates, the biological activity is lost. Discard the vial and reconstitute a fresh one using proper technique.

Shaking introduces mechanical shear that can break peptide bonds, but the extent of damage depends on duration and force. If you shook briefly (under 10 seconds), bioavailability loss is likely minimal. Refrigerate immediately and use within 21 days instead of the standard 28-day window. If shaking was vigorous or prolonged, expect reduced potency. There's no way to reverse peptide denaturation once it occurs. For research applications requiring precise dosing, prepare a fresh vial using proper technique.

The reconstituted solution must be used within 24 hours and cannot be stored for later use. Sterile water lacks the benzyl alcohol preservative that inhibits bacterial growth. Any microorganisms introduced during reconstitution or subsequent needle insertions will proliferate rapidly at room temperature and moderately even under refrigeration. If you must use sterile water, draw your full dose immediately after reconstitution, transfer it to a sterile sealed vial, and refrigerate that single-dose vial. Do not return to the original vial for additional draws. For multi-dose protocols, bacteriostatic water is non-negotiable.

Allow an additional 5–10 minutes of passive dissolution before intervening. Epithalon's solubility is temperature-dependent. Refrigerated bacteriostatic water dissolves powder more slowly than room-temperature water, but room-temperature reconstitution accelerates degradation the moment mixing begins. If visible powder remains after 15 minutes, gently roll the vial between your palms without shaking. Circular motion maintains sterility while encouraging dissolution. Never heat the vial or use a vortex mixer, both of which denature the tetrapeptide structure irreversibly.

Assess the solution for foam or bubbles. If significant foaming occurred (more than 20% of the liquid volume appears as foam), let the vial sit undisturbed at room temperature for 10–15 minutes to allow bubbles to dissipate, then inspect for clarity. Foaming itself doesn't guarantee denaturation. But rapid injection creates shear forces that can disrupt protein folding. If the solution clears completely after foam subsides, it's likely still viable. Future reconstitutions: aim for 1mL per 10 seconds injection speed.

Reconstitute at the coolest ambient temperature available (ideally below 20°C), use the solution immediately, and discard any unused portion. NAD+ stability at room temperature post-reconstitution is approximately 4–6 hours before measurable oxidative degradation begins. If your research protocol requires multi-dose administration, refrigerated storage between uses is non-negotiable. Bacteriostatic water's antimicrobial properties prevent bacterial growth, but they don't slow NAD+ oxidation at warm temperatures.

Use an insulated medication cooler that maintains 2–8°C without freezing. Never pack reconstituted peptide vials directly against ice packs; freezing destroys the protein structure irreversibly. For transport longer than 48 hours, use a portable laboratory refrigerator with digital temperature logging. Even brief freezing (under 30 minutes) causes aggregation visible as cloudiness after thawing. There's no recovery once this occurs.

Continue swirling gently for an additional 2–3 minutes. Most lyophilised peptides require 3–5 minutes of total contact time for complete dissolution. If visible powder remains after five minutes, the vial may have been stored improperly before reconstitution (exposure to humidity causes clumping that resists dissolution). Do not inject additional water or attempt to break up clumps with the needle. This introduces contamination and dilutes your final concentration unpredictably. Discard the vial and start with fresh powder. Partial dissolution means uneven dosing across the vial's lifespan. The first few draws will be under-dosed while the last few are over-concentrated.

Discard the vial. Cloudiness indicates incomplete dissolution or peptide aggregation, both of which mean the TB-4 is no longer structurally intact. The most common causes are expired lyophilised peptide, improper storage before reconstitution (temperatures above −20°C), or forceful water injection that caused supersaturation. Do not attempt to salvage cloudy solutions by heating, adding more water, or continuing to swirl. The peptide bonds are already disrupted.

Use the reconstituted solution immediately and discard any unused portion after your first draw—do not store it for multi-dose use. Sterile water lacks the benzyl alcohol preservative that inhibits bacterial growth, which means bacterial contamination begins proliferating within 24–48 hours even under refrigeration. The standard 28-day use window for bacteriostatic-water-reconstituted peptides does not apply to sterile-water solutions. If you've already stored a sterile-water-reconstituted vial for more than 48 hours, discard it regardless of how much remains—bacterial colony counts at 72+ hours routinely exceed safe thresholds even when proper aseptic technique was followed during mixing.

Give it 10–15 minutes at room temperature. Some peptides dissolve slower than others, especially if the lyophilised cake was densely packed. If cloudiness persists beyond 15 minutes, gently roll the vial between your palms. If it remains cloudy after rolling, the peptide has likely aggregated due to improper storage before you received it (temperature excursion during shipping) or expired bacteriostatic water. Do not use cloudy solutions. Aggregated peptides have unpredictable pharmacokinetics and increased immunogenicity risk.

Use an insulated medical transport case with gel ice packs rated to maintain 2–8°C for at least 12 hours. The same equipment used for insulin transport works for peptides. Epithalon tolerates brief temperature excursions (up to 25°C for 2–3 hours) without complete denaturation, but every hour above 8°C accelerates oxidation and reduces potency by approximately 3–5%. If you're transporting the vial for longer than 6 hours, include a small digital thermometer in the case to verify temperature stability. Once you reach your destination, refrigerate the vial immediately. Do not leave it at room temperature while setting up other equipment.

Allow the vial to sit upright and refrigerated for 60 minutes so air bubbles rise to the headspace naturally. Drawing solution while air bubbles remain suspended risks pulling air into the syringe, which creates injection site discomfort and reduces dose accuracy. If bubbles persist after 60 minutes, the peptide is likely compromised by excessive agitation. Consider the vial suspect and order replacement material rather than risk experimental variability.

The damage is done, but the solution is still usable. Just less potent than intended. Mechanical shear from forceful injection fragments 10–15% of the peptide mass, reducing bioactivity but not eliminating it entirely. Use the reconstituted solution within 14 days instead of the standard 28-day window, and store it at the coldest end of your refrigerator's range (2–4°C) to slow further degradation. For future reconstitutions, slow your injection rate to 1ml per 10 seconds and angle the needle against the glass wall.

Discard the vial and contact your supplier. Lyophilised FOXO4-DRI should appear as a white or off-white fluffy cake at the vial bottom. Yellow discoloration, hard clumping, or oily residue indicates degradation during shipping or storage. Likely from temperature excursion above 25°C or moisture intrusion through a compromised seal. Reconstituting degraded peptide won't restore potency.

Discard the solution and mix a new vial. Reconstituted peptides stored above 8°C for more than 4 hours undergo measurable degradation. The benzyl alcohol preservative in bacteriostatic water prevents bacterial growth but does not protect against thermal degradation of the peptide backbone. Kisspeptin-10 has a calculated half-life of approximately 72 hours at room temperature (25°C) in aqueous solution, meaning 50% potency loss within three days. Refrigeration at 2–8°C extends stability to 28 days by slowing enzymatic and oxidative degradation pathways. Temperature excursions cannot be reversed.